These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 611915)

  • 21. Pharmacokinetics of drugs in patients with the nephrotic syndrome.
    Gugler R; Shoeman DW; Huffman DH; Cohlmia JB; Azarnoff DL
    J Clin Invest; 1975 Jun; 55(6):1182-9. PubMed ID: 1133166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of acebutolol dialysis and pharmacokinetic data in patients with renal insufficiency undergoing hemodialysis].
    Roux A; Aubert P; Guédon J; Flouvat B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3228-33. PubMed ID: 1219629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of free non-protein bound clofibrinic acid after single dosing to patients with impaired renal function of various degrees--a multicenter study.
    Merk W; Graben N; Hartmann H; Nikolaus C; Schlierf G; Schwandt P
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):59-62. PubMed ID: 3557732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetic and biological effective time of beta-receptor blockers in renal insufficiency].
    Knauf H; Schäfer-Korting M; Mutschler E
    Internist (Berl); 1981 Oct; 22(10):616-21. PubMed ID: 6117538
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clofibrate pharmacokinetics in chronic renal failure (author's transl)].
    Millart H; Lavaud S; Brunois JP; Lamiable D; Choisy H; Chanard J
    Therapie; 1980; 35(6):705-16. PubMed ID: 7233360
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibiotics and renal insufficiency (author's transl)].
    Bonfils P
    Schweiz Rundsch Med Prax; 1981 Mar; 70(11):471-6. PubMed ID: 7012822
    [No Abstract]   [Full Text] [Related]  

  • 28. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.
    Verbeeck RK
    Drug Metab Dispos; 1982; 10(1):87-9. PubMed ID: 6124391
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug elimination by hemofiltration.
    Rumpf KW; Rieger J; Doht B; Ansorg R; Scheler F
    J Dial; 1977; 1(7):677-8. PubMed ID: 608876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in trimethoprim levels and its pharmacokinetic parameters in children with chronic renal failure treated with biseptol. I].
    Sieniawska M; Białasik D; Wróblewska-Kałuzewska M; Korniszewska J; Wierzbowska-Lange B; Karczeńska J; Wierzba K
    Pediatr Pol; 1984 Mar; 59(3):177-87. PubMed ID: 6610853
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of sulphadimidine (sulphamezathine) in patients with renal failure.
    Adam WR; Brown DJ; Hales P; Dawborn JK
    Med J Aust; 1973 May; 1(19):936-8. PubMed ID: 4715400
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study, by means of a spectrofluorometric method, of plasma concentrations of doxycycline and of the elimination of this antibiotic in urine or dialysis fluid in patients with severe chronic kidney failure].
    Gavend M; Muller JM; Bessard G; Meftahi H; Debru JL; Cordonnier D
    Therapie; 1972; 27(5):925-36. PubMed ID: 4651413
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
    Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Elimination of drugs in patients with renal insufficiency].
    Dettli L
    Schweiz Rundsch Med Prax; 1973 Apr; 62(15):476-8. PubMed ID: 4695201
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal excretion of magnesium in chronic kidney insufficiency].
    Karakascheva VV
    Z Med Lab Diagn; 1980; 21(3):155-62. PubMed ID: 7434861
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetics of biosynthetic human proinsulin in patients with terminal renal insufficiency.
    Zilker TR; Rebel C; Kopp KF; Wahl K; Ermler R; Heinzel G; Hales CN; Bottermann P
    Horm Metab Res Suppl; 1988; 18():43-8. PubMed ID: 3056810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of vecuronium in patients with end-stage renal failure.
    Meistelman C; Lienhart A; Leveque C; Bitker MO; Pigot B; Viars P
    Eur J Anaesthesiol; 1986 Mar; 3(2):153-8. PubMed ID: 2877876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic].
    Lücker PW; Wetzelsberger K; Erking W; Donike M
    Arzneimittelforschung; 1980; 30(11b):2045-53. PubMed ID: 7194058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.